Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Pilot study of ketamine in phobic participants using virtual reality stimuli


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12619001504101

Organisation Name: University of Otago

Overal Status: Not yet recruiting

Start Date: 11/11/2019

Brief Summary: We hypothesise that Ketamine could be used therapeutically to manage phobic situations that interfere with health or business activities (e.g. needle phobic patients getting medical/dental procedures; aeroplane/flight phobic patients needing to travel by air).
The purpose of the study is to evaluate the effect of oral doses of ketamine and the active control, midazolam, on anxiety ratings in participants with spider phobia.
Images of spiders will be presented to participants via a virtual reality (VR) headset. 5 spider encounters will be presented that vary in terms of size, activity level and proximity of the VR spider to the participant.
Changes in anxiety and phobia ratings, heart rate and skin response will be obtained pre-dose and immediately after each VR spider exposure.

Countries:
  • New Zealand


Total execution time in seconds: 0.11848187446594